(Press-News.org) Knee and hip replacements are increasing globally due to an ageing population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next 7 years. Post-surgery infections, while rare at 1-5% of patients, result in high patient morbidity and mortality.
In the United States the annual national hospital costs for treating infection are projected to exceed $1.85 billion.
We currently use an antibiotic, cefazolin, at the time of surgery to prevent infection. But with the rise of antibiotic resistant bacteria, experts have debated whether adding a second antibiotic, vancomycin, would be better to prevent more infection. Vancomycin is a commonly used antibiotic for MRSA (methicillin resistant Staphylococcus aureus, or “golden Staph”). Many centres in Australia and globally had adopted the practice of giving both cefazolin and vancomycin to prevent infections, despite the lack of clear benefit.
Now a clinical trial, published today in the New England Journal of Medicine and led by Monash University researchers, in collaboration with orthopaedic surgeons and infectious diseases doctors, has found that the addition of vancomycin did not protect against infection and may have led to more infections and more adverse reactions for the patients.
According to the study lead, Professor Trisha Peel, from the Monash University Central Clinical School, “Given the number of joint replacements performed in Australia and globally, our trial has answered the important about whether more antibiotics are better for our patients having joint replacement surgery: with the definitive answer being “no”. This trial will have a significant impact on practice,” she said.
The Australian Surgical Antibiotic Prophylaxis (ASAP) trial looked at 4239 patients without a history of MRSA, in 11 hospitals across Australia, including regional and private hospitals. Patients were randomised to receive receive either vancomycin or saline placebo, in combination with cefazolin. Among all patients, the addition of vancomycin was no better than the traditional cefazolin antibiotic. Unexpectedly, in patients undergoing knee joint replacement, the risk of infection was higher in the vancomycin group, 5.7%, than in the placebo group, with 3.7% infection rate.
Professor Peel said that the study reflects how important these large, randomised, multi-centre clinical trials are “"A lot of things seem to make sense, but we don't really know for sure until they are tested in a clinical trial.” Prof Peel said “This is one of those cases - more antibiotics weren't better, and in some people might have actually been worse.",” she said.
END
More is not better: Trial finds giving more antibiotics to prevent joint replacement infections doesn't help
In joint replacement infection - vancomycin does not protect against infection and may lead to more infections
2023-10-18
ELSE PRESS RELEASES FROM THIS DATE:
Promising new options for treating aggressive prostate cancer
2023-10-18
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment. The results of their international Phase III clinical trial were published today in the New England Journal of Medicine.
“If these treatments are approved by the Food and Drug Administration, our results will be practice changing,” said Stephen Freedland, MD, associate director for Training and Education and the Warschaw, Robertson, ...
Liverpool chemist presented with 2023 Eni Energy Frontiers Award by President of Italy
2023-10-18
Professor Matt Rosseinsky, from the University of Liverpool’s Department of Chemistry and Materials Innovation Factory, was presented with the 2023 Eni Energy Frontiers Award by Sergio Mattarella, the President of the Republic of Italy, at a ceremony in Rome this week.
Professor Rosseinsky received the prestigious Eni Award for the digital design and discovery of next-generation energy materials.
The presentation ceremony took place at the Palazzo del Quirinale in Rome which was also attended by Giuseppe Zafarana, Chairman of Eni and Claudio Descalzi, CEO of Eni.
Professor Rosseinsky said: “It was a great honour to be presented with this award by the President ...
Study focusing on Black cancer survivors documents how exposure to racial discrimination impacts care
2023-10-18
The medical community has understood for some time that experiences with discrimination are bad for the health of people from underserved racial or ethnic groups — populations burdened with worse health outcomes than white patients for conditions including many cancers. The effects of chronic stress on the body have been considered one chief culprit.
Now, a research team from the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center, supported in part by the National Institutes of Health, has added new knowledge about how Black patients in particular are impacted by exposure to discrimination in the course of cancer care. Through interviews ...
Choosing exoskeleton settings like a Pandora radio station
2023-10-18
Images // Video
Taking inspiration from music streaming services, a team of engineers at the University of Michigan, Google and Georgia Tech has designed the simplest way for users to program their own exoskeleton assistance settings.
Of course, what's simple for the users is more complex underneath, as a machine learning algorithm repeatedly offers pairs of assistance profiles that are most likely to be comfortable for the wearer. The user then selects one of these two, and the predictor offers another ...
School discipline referrals for substance use increased in Oregon middle schools after legalization of recreational marijuana
2023-10-18
School Discipline Referrals for Substance Use Increased in Oregon Middle Schools after Legalization of Recreational Marijuana
A recent study found that Oregon middle school students received office discipline referrals (ODRs) for substance use offenses 30% more often after legalization of recreational marijuana relative to comparison schools in other states over the same period (school years 2012/2013 – 2018/2019). There were no statistically discernable changes in high school ODRs. Recreational use by adults was legalized in Oregon in 2015.
Researchers examined the extent to which legalization of recreational marijuana ...
UMass Amherst engineering professor is awarded $1.9 million to push the bounds of cancer, heart disease research
2023-10-18
UMass Amherst Engineering Professor Is Awarded $1.9 Million to Push the Bounds of Cancer, Heart Disease Research
Jinglei Ping will explore a new method of controlling cell communication by electronically regulating exosome traffic through the National Institutes of Health grant
AMHERST, Mass. — The human body is a sophisticated organism that has complex internal communication systems down to a cellular level. However, these systems transmit more than just messages about healthy human functions; they can also influence disease.
Consider cancer. Jinglei Ping poses the question: “How do unhealthy cells transport their own cancer ...
American Society of Anesthesiologists names Ronald L. Harter, M.D., FASA, new president
2023-10-18
SAN FRANCISCO — Ronald L. Harter, M.D., FASA, professor of anesthesiology in the Department of Anesthesiology at The Ohio State University Wexner Medical Center in Columbus, was today named president of the American Society of Anesthesiologists (ASA), the nation’s largest organization of physician anesthesiologists. Dr. Harter assumed office at the ANESTHESIOLOGY® 2023 annual meeting and will serve for one year.
“ASA is the premier educational, research and scientific organization representing anesthesiology in the U.S., and I’m honored to have this opportunity to advance ...
Study finds increased risk of Guillain-Barré after COVID-19 infection
2023-10-18
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 18, 2023
MINNEAPOLIS – Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the ...
Protecting polar bears aim of new and improved radar technology
2023-10-18
Research testing new technology to more effectively locate polar bear dens across the Arctic is showing promising results. Researchers from Simon Fraser University and Brigham Young University (BYU), collaborating with Polar Bears International, hope that improving detection tools to locate dens—which are nearly invisible and buried under snow—will help efforts to protect mother polar bears and their cubs.
Results of a pilot study aimed at improving den location in Churchill, Manitoba—using ARTEMIS Inc., an imaging system that relies on Synthetic Aperture Radar, or SAR—are published this week ...
From one nightmare to another. Anthony Fauci’s new concern
2023-10-18
(WASHINGTON) -- “What keeps you up at night?”
It’s a question Anthony Fauci, MD, heard repeatedly over the course of his nearly four decades as director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Now a Distinguished University Professor at Georgetown University School of Medicine and the McCourt School of Public Policy, Fauci says he realized his worst nightmare -- a twist on the usual question -- in January 2020 when the type of virus he most feared triggered a worldwide pandemic.
Today, as the COVID-19 pandemic wanes, Fauci describes a new nemesis ...
LAST 30 PRESS RELEASES:
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
Water fluoridation less effective now than in past
Toddlers get nearly half their calories from ultra-processed foods
Detroit researchers to examine links between bacterial infections, environmental pollution and preterm birth
In lab tests, dietary zinc inhibits AMR gene transmission
Two UMD Astronomy space probes advance to next round of $1 billion NASA mission selection
New MSU research sheds light on impact and bias of voter purging in Michigan
Funding to create world's first ovarian cancer prevention vaccine
Scientists develop novel method for strengthening PVC products
Houston Methodist part of national consortium to develop vaccine against herpesviruses
UT Health San Antonio School of Dentistry earns first NIH grant under new center for pain therapeutics and addiction research
Do MPH programs prepare graduates for employment in today's market? Mostly yes, but who is hiring may be surprising
New article provides orientation to using implementation science in policing
Three beer-related discoveries to celebrate Oktoberfest
AAAS launches user research project to inform the new AAAS.org
In odd galaxy, NASA's Webb finds potential missing link to first stars
Adding beans and pulses can lead to improved shortfall nutrient intakes and a higher diet quality in American adults
What happens in the brain when a person with schizophrenia “hears voices”?
Ant agriculture began 66 million years ago in the aftermath of the asteroid that doomed the dinosaurs
A new era of solar observation
The true global impact of species-loss caused by humans is far greater than expected – new study reveals
Smartphone-assisted “scavenger hunt” identifies people at risk for dementia
Green subsidies may have hidden costs, experts warn
Small brains can accomplish big things, according to new theoretical research
UTA professor honored for science education leadership
Decline of mpox antibody responses after modified vaccinia Ankara–Bavarian Nordic vaccination
Wider use of convalescent plasma might have saved thousands more lives during pandemic
Strong coupling between Andreev qubits mediated by a microwave resonator
UNF biological sciences professor receives NIH grant to study muscle atrophy
Child Health Day 2024: influenza vaccine protects children from infection and hospitalization for the disease, Spanish study shows
[Press-News.org] More is not better: Trial finds giving more antibiotics to prevent joint replacement infections doesn't helpIn joint replacement infection - vancomycin does not protect against infection and may lead to more infections